Mar 28, 2024 / 09:00PM GMT
Operator
Good day, everyone, and welcome to Vivos Therapeutics Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions)
This conference is being recorded and a replay of today's call will be available on the Investor Relations section of Vivos website and will remain posted there for the next 30 days.
I will now hand over the call to Julie Gannon, Vivos Investor Relations Officer for introductions and the reading of the Safe Harbor statement. Please go ahead.
Julie Gannon - Vivos Therapeutics Inc - Investment Relations Officer
Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.gevo.com. With us on today's call are Kirk Huntsman, David DeVoe, Chairman and Chief Executive Officer, and Brad Almond, Chief Financial Officer.
Today will review the highlights and financial results for the fourth quarter and full year 2023, as well as more recent
Q4 2023 Vivos Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot